Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules

被引:256
作者
Mosqueira, VCF
Legrand, P
Gulik, A
Bourdon, O
Gref, R
Labarre, D
Barratt, G
机构
[1] Univ Paris Sud, Fac Pharm, Lab Physicochim, CNRS,UMR 8612, F-92296 Chatenay Malabry, France
[2] Ctr Mol Genet, UPR A2420, F-91198 Gif Sur Yvette, France
[3] Univ Paris 06, CNRS, UPRESA 7033, LPBC, F-75252 Paris, France
[4] Univ Fed Ouro Preto, Escola Farm, Dept Farm, BR-35400000 Ouro Preto, Minas Gerais, Brazil
关键词
nanocapsules; poly(D; L-lactide-co-ethylene oxide) copolymers; complement activation; cellular uptake; physicochemical characterization; surface properties;
D O I
10.1016/S0142-9612(01)00043-6
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of our work was to examine the relationship between modifications of the surface of nanocapsules (NC) by adsorption or covalent grafting of poly(ethylene oxide) (PEG), and changes in their phospholipid (PL) content on complement activation (C3 cleavage) and on uptake by macrophages. The physicochemical characterization of the NC included an investigation of their properties, such as surface charge, size, hydrophilicity, morphology and homogeneity. This is the first time that such properties have been correlated with biological interactions for NC, a novel carrier system with a structure more complex than nanospheres. C3 crossed immunoelectrophoresis revealed the reduced activation for NC with longer PEG chain and higher density, although all formulations induced C3 cleavage to a lesser or greater extent. NC bearing PEG covalently bound to the surface were weaker activators of complement than plain PLA [poly(D,L-lactide)] NC or nanospheres (NS). Furthermore, the fluorescent/confocal microscopy of J774A1 cells in contact with NC reveal a dramatically reduced interaction with PEG-bearing NC However, the way in which PEG was attached (covalent or adsorbed) seemed to affect the mechanism of uptake. Taken together, these results suggest that the low level of protein binding to NC covered with a high density of 20 kDa PEG chains is likely to be due to the steric barriers surrounding these particles, which prevents protein adsorption and reduces their interaction with macrophages. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2967 / 2979
页数:13
相关论文
共 34 条
[1]  
Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO
[2]  
2-9
[3]   Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells [J].
Batrakova, EV ;
Han, HY ;
Miller, DW ;
Kabanov, AV .
PHARMACEUTICAL RESEARCH, 1998, 15 (10) :1525-1532
[4]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[5]  
Buscall R, 1986, POLYM COLLOIDS, P141
[6]   ADSORPTION OF ETHOXYLATED SURFACTANTS ON NANOPARTICLES .1. CHARACTERIZATION BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY [J].
CARSTENSEN, H ;
MULLER, BW ;
MULLER, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 67 (01) :29-37
[7]  
CHONN A, 1991, J IMMUNOL, V146, P4234
[8]   NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4
[9]   'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption [J].
Gref, R ;
Lück, M ;
Quellec, P ;
Marchand, M ;
Dellacherie, E ;
Harnisch, S ;
Blunk, T ;
Müller, RH .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 18 (3-4) :301-313
[10]   THE CONTROLLED INTRAVENOUS DELIVERY OF DRUGS USING PEG-COATED STERICALLY STABILIZED NANOSPHERES [J].
GREF, R ;
DOMB, A ;
QUELLEC, P ;
BLUNK, T ;
MULLER, RH ;
VERBAVATZ, JM ;
LANGER, R .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :215-233